These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16470355)
21. Chemotherapy for advanced testicular cancer. Fox EP; Loehrer PJ Hematol Oncol Clin North Am; 1991 Dec; 5(6):1173-87. PubMed ID: 1723407 [TBL] [Abstract][Full Text] [Related]
22. High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Papadakis V; Dunkel IJ; Cramer LD; Kramer E; Papadopoulos E; Goldman S; Packer RJ; Willoughby M; Baker D; Garvin J; Strandjord S; Coccia P; Kaplan AM; Klemperer M; Finlay JL Bone Marrow Transplant; 2000 Jul; 26(2):153-60. PubMed ID: 10918425 [TBL] [Abstract][Full Text] [Related]
23. Diagnosis and management of drug-associated interstitial lung disease. Müller NL; White DA; Jiang H; Gemma A Br J Cancer; 2004 Aug; 91 Suppl 2(Suppl 2):S24-30. PubMed ID: 15340375 [TBL] [Abstract][Full Text] [Related]
24. Idiopathic interstitial pneumonias: translating our current understanding into novel therapies. King TE Exp Lung Res; 2005 Sep; 31 Suppl 1():41-6. PubMed ID: 16395857 [No Abstract] [Full Text] [Related]
25. [Limits and value of chemotherapy in elderly patients]. Engert A; Schnell R; Lathan B; Diehl V Med Klin (Munich); 1994 Nov; 89(11):603-10. PubMed ID: 7815990 [No Abstract] [Full Text] [Related]
26. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia. Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Schagen SB Crit Rev Oncol Hematol; 2013 Oct; 88(1):87-101. PubMed ID: 23768778 [TBL] [Abstract][Full Text] [Related]
27. [New hormones and cytostatic drugs in tumor therapy]. Lüftner D; Possinger K Internist (Berl); 1997 Nov; 38(11):1037-44. PubMed ID: 9453951 [No Abstract] [Full Text] [Related]
29. [Drug-induced interstitial lung diseases]. Bonniaud P; Georges M; Favrolt N; Camus P Rev Prat; 2014 Sep; 64(7):951-6. PubMed ID: 25362778 [TBL] [Abstract][Full Text] [Related]
30. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736 [TBL] [Abstract][Full Text] [Related]
31. Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed. Stavroulopoulos A; Nakopoulou L; Xydakis AM; Aresti V; Nikolakopoulou A; Klouvas G Ren Fail; 2010; 32(8):1000-4. PubMed ID: 20722569 [TBL] [Abstract][Full Text] [Related]
33. [Key features in the management of diffuse interstitial pulmonary disease]. Fernández DI; Sánchez RP; Moreno AF; Fernández Fabrellas E Arch Bronconeumol; 2009; 45 Suppl 3():3-8. PubMed ID: 20116737 [TBL] [Abstract][Full Text] [Related]
34. Late toxicity in survivors from adolescent cancers. Pentheroudakis G; Pavlidis N Cancer Treat Rev; 2007 Nov; 33(7):656-63. PubMed ID: 17640814 [TBL] [Abstract][Full Text] [Related]
35. Treatment of childhood cancers: late effects. Prescrire Int; 2015 Oct; 24(164):236-9. PubMed ID: 26594727 [TBL] [Abstract][Full Text] [Related]
36. Tubulointerstitial nephritis and cancer chemotherapy: update on a neglected clinical entity. Airy M; Raghavan R; Truong LD; Eknoyan G Nephrol Dial Transplant; 2013 Oct; 28(10):2502-9. PubMed ID: 24009289 [TBL] [Abstract][Full Text] [Related]
37. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight. Min JH; Lee HY; Lim H; Ahn MJ; Park K; Chung MP; Lee KS Cancer Chemother Pharmacol; 2011 Nov; 68(5):1099-109. PubMed ID: 21913033 [TBL] [Abstract][Full Text] [Related]